Cargando…

Targeting SREBP1 chemosensitizes colorectal cancer cells to gemcitabine by caspase-7 upregulation

Biomarkers for predicting chemotherapy response are important for treatment of colorectal cancer (CRC) patients.SREBP1is involved in cancer cell chemoresistance, but the biological consequences of this activity in CRC are poorly understood. We set up biochemical and cell biology analyzes to analyze...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Wenlong, Xu, Ting, Chen, Dong, Tan, Xiaojie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802928/ https://www.ncbi.nlm.nih.gov/pubmed/31601152 http://dx.doi.org/10.1080/21655979.2019.1676485

Ejemplares similares

FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1
por: Hu, Qiangsheng, et al.
Publicado: (2017)

miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis()()
por: Fassan, Matteo, et al.
Publicado: (2018)

Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine
por: Lankadasari, Manendra Babu, et al.
Publicado: (2018)

SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-κB pathway activation
por: Gao, Yuyan, et al.
Publicado: (2019)

Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1
por: Zhou, Jing-ping, et al.
Publicado: (2020)

Low Expression of Smurf1 Enhances the Chemosensitivity of Human Colorectal Cancer to Gemcitabine and Cisplatin in Patient-Derived Xenograft Models
por: Guo, Jing, et al.
Publicado: (2020)

Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1
por: Zhou, Cancan, et al.
Publicado: (2018)

Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine
por: Zhang, He, et al.
Publicado: (2022)

Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy
por: Wang, Sheng, et al.
Publicado: (2021)

Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma
por: Suksawat, Manida, et al.
Publicado: (2022)

Interplay of PKD3 with SREBP1 Promotes Cell Growth via Upregulating Lipogenesis in Prostate Cancer Cells
por: Li, Ling, et al.
Publicado: (2019)

Enhanced chemosensitization of anoikis-resistant melanoma cells through syndecan-2 upregulation upon anchorage independency
por: Tseng, TingTing, et al.
Publicado: (2017)

LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer
por: Zhang, Xianbin, et al.
Publicado: (2019)

Targeting colorectal cancer stem cells with inducible caspase-9
por: Kemper, Kristel, et al.
Publicado: (2012)

α‐Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades
por: Shi, Yu, et al.
Publicado: (2019)

Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway
por: Zhang, Juan, et al.
Publicado: (2022)

Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells
por: Xing, Hai-Bo, et al.
Publicado: (2018)

PIG7 promotes leukemia cell chemosensitivity via lysosomal membrane permeabilization
por: Liu, Jiazhuo, et al.
Publicado: (2015)

SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer
por: Jin, Yuxiao, et al.
Publicado: (2021)

MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7
por: Cui, Ri, et al.
Publicado: (2015)

MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy
por: Lu, Huimin, et al.
Publicado: (2019)

Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
por: Toden, Shusuke, et al.
Publicado: (2016)

Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer
por: Wang, Xiaoyu, et al.
Publicado: (2017)

Eicosapentaenoic acids enhance chemosensitivity through connexin 43 upregulation in murine melanoma models
por: Yang, Chih-Jen, et al.
Publicado: (2019)

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”
por: Xing, Hai-Bo, et al.
Publicado: (2022)

HCBP6 upregulates human SREBP1c expression by binding to C/EBPβ-binding site in the SREBP1c promoter
por: Yang, Xueliang, et al.
Publicado: (2018)

Genistein upregulates LDLR levels via JNK-mediated activation of SREBP-2
por: Kartawijaya, Medicia, et al.
Publicado: (2016)

SREBP-1 upregulates lipophagy to maintain cholesterol homeostasis in brain tumor cells
por: Geng, Feng, et al.
Publicado: (2023)

MTERFD1 promotes cell growth and irradiation resistance in colorectal cancer by upregulating interleukin-6 and interleukin-11
por: Liu, Xiaoshuang, et al.
Publicado: (2019)

Caspase-11 contributes to site-1 protease cleavage and SREBP1 activation in the inflammatory response of macrophages
por: Cheng, Yinglan, et al.
Publicado: (2023)

Lipid-cell cycle nexus: SREBP regulates microRNAs targeting Fbxw7
por: Esquejo, Ryan M, et al.
Publicado: (2014)

Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer
por: Nishiguchi, Yukiko, et al.
Publicado: (2019)

miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis
por: Yang, Rui-Meng, et al.
Publicado: (2017)

Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer Cells
por: Wang, Yongwei, et al.
Publicado: (2012)

Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells
por: Kreutzer, Jan N, et al.
Publicado: (2010)

SREBP-2, a new target of metformin?
por: Zhang, Fengxia, et al.
Publicado: (2018)

Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2
por: Wang, Siying, et al.
Publicado: (2023)

MicroRNA‐375‐3p enhances chemosensitivity to 5‐fluorouracil by targeting thymidylate synthase in colorectal cancer
por: Xu, Fei, et al.
Publicado: (2020)

MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer
por: Yao, Hui, et al.
Publicado: (2019)

Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
por: Xue, Linyuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3e9glglrcvi14qinhn4aiago3q